Atlas Trials

Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer

Clinical trial NCT06775470 · RECRUITING

Trial details

NCT number
NCT06775470
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Status
RECRUITING
Study type
OBSERVATIONAL
Ovarian Cancer
Start date
2022-07-01
Primary completion
2025-12-31
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.